BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1933399)

  • 1. Effects of trazodone and m-chlorophenylpiperazine (m-CPP) on acute dependence in mice.
    Valeri P; Pimpinella G; Troiani MP; Morrone LA; Romanelli L
    Brain Res Bull; 1991 May; 26(5):799-802. PubMed ID: 1933399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antinociceptive effects of trazodone and m-chlorophenylpiperazine (mCPP) in mice: interaction with morphine.
    Valeri P; Pimpinella G; Morrone LA; Romanelli L
    Gen Pharmacol; 1991; 22(1):127-31. PubMed ID: 2050281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative pharmacological study of trazodone, etoperidone and 1-(m-chlorophenyl)piperazine.
    Cioli V; Corradino C; Piccinelli D; Rocchi MG; Valeri P
    Pharmacol Res Commun; 1984 Jan; 16(1):85-100. PubMed ID: 6701182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naloxone-precipitated abstinence in mice, rats and gerbils acutely dependent on morphine.
    Ramabadran K
    Life Sci; 1983; 33 Suppl 1():385-8. PubMed ID: 6686634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of dapiprazole, clonidine and yohimbine on the development of dependence and withdrawal behaviour in mice.
    Valeri P; Martinelli B; Pimpinella G; Severini C
    Drug Alcohol Depend; 1989 Jan; 23(1):73-7. PubMed ID: 2920669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant-like effects of trazodone on a behavioral screen are mediated by trazodone, not the metabolite m-chlorophenylpiperazine.
    Li AA; Marek GJ; Hand TH; Seiden LS
    Eur J Pharmacol; 1990 Feb; 177(3):137-44. PubMed ID: 2311675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade by trazodone of naloxone-precipitated jumping on morphine-dependent rats: correlation with brain levels of m-chlorophenylpiperazine.
    Cervo L; Ballabio M; Caccia S; Samanin R
    J Pharm Pharmacol; 1981 Dec; 33(12):813-4. PubMed ID: 6121864
    [No Abstract]   [Full Text] [Related]  

  • 8. Prolongation of thiopentone-induced sleep by trazodone and its metabolite, m-chlorophenylpiperazine.
    Adamus A; Sansone M; Melzacka M; Vetulani J
    J Pharm Pharmacol; 1985 Jul; 37(7):504-6. PubMed ID: 2863360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formalin-induced pain antagonizes the development of opiate dependence in the rat.
    Vaccarino AL; Couret LC
    Neurosci Lett; 1993 Oct; 161(2):195-8. PubMed ID: 8272266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of withdrawal in reinstatement of morphine-conditioned place preference.
    Lu L; Chen H; Su W; Ge X; Yue W; Su F; Ma L
    Psychopharmacology (Berl); 2005 Aug; 181(1):90-100. PubMed ID: 15739075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial inhibition of the abstinence syndrome in morphine tolerant-dependent mice following pharmacological denervation.
    Contreras E; Tamayo L; Quijada L
    Arch Int Pharmacodyn Ther; 1978 Sep; 235(1):124-33. PubMed ID: 310664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats.
    Aricioglu-Kartal F; Uzbay IT
    Life Sci; 1997; 61(18):1775-81. PubMed ID: 9365224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations of adenosine A1 receptors in morphine dependence.
    Kaplan GB; Leite-Morris KA; Sears MT
    Brain Res; 1994 Sep; 657(1-2):347-50. PubMed ID: 7820640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
    Lu L; Liu D; Ceng X; Ma L
    Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic mechanisms in precipitated withdrawal in morphine-dependent rats.
    Ary M; Cox B; Lomax P
    J Pharmacol Exp Ther; 1977 Feb; 200(2):271-6. PubMed ID: 557107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of conditioned avoidance responding by trazodone, etoperidone, and MCPP.
    Martin GE; Mathiasen JR; Kesslick JM
    Psychopharmacology (Berl); 1989; 99(1):94-7. PubMed ID: 2506609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nonpeptidic delta opioid receptor agonist, BW373U86, attenuates the development and expression of morphine abstinence precipitated by naloxone in rat.
    Lee PH; McNutt RW; Chang KJ
    J Pharmacol Exp Ther; 1993 Nov; 267(2):883-7. PubMed ID: 8246163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antipsychotic and antianxiety drugs on the morphine abstinence syndrome in rats.
    Baldino F; Cowan A; Geller EB; Adler MW
    J Pharmacol Exp Ther; 1979 Jan; 208(1):63-6. PubMed ID: 32386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trazodone and its active metabolite m-chlorophenylpiperazine as partial agonists at 5-HT1A receptors assessed by [35S]GTPgammaS binding.
    Odagaki Y; Toyoshima R; Yamauchi T
    J Psychopharmacol; 2005 May; 19(3):235-41. PubMed ID: 15888508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of 5-HT2C receptors in mediating the discriminative stimulus properties of m-chlorophenylpiperazine (mCPP).
    Callahan PM; Cunningham KA
    Eur J Pharmacol; 1994 May; 257(1-2):27-38. PubMed ID: 8082704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.